Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Stijn De Keukeleire

Faculty of Medicine and Health Sciences > Department of Basic and Applied Medical Sciences

Work address: C. Heymanslaan 10, ingang 12 - verdieping 2
9000 Gent
Email: StijnJ.DeKeukeleire@UGent.be

Show Sort by

Add to list
- Journal Article
- A1
- open access
An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

Astrid De Meulenaere, Tijl Vermassen (UGent) , David Creytens (UGent) , Stijn De Keukeleire (UGent) , Tim Delahaye, Philippe Deron (UGent) , Fréderic Duprez (UGent) , Samson Fung, Patrick Pauwels, Liesbeth Ferdinande (UGent) , et al.

(2021) CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 14(6). p.2300-2313
Add to list
Tumour infiltrating lymphocytes in oropharyngeal carcinoma : prognostic value and evaluation of a standardised method

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Astrid De Meulenaere, Philippe Deron (UGent) , Wouter Huvenne (UGent) , Fréderic Duprez (UGent) , David Creytens (UGent) , Jo Van Dorpe (UGent) , Sylvie Rottey (UGent) and Liesbeth Ferdinande (UGent)

(2021) PATHOLOGY. 53(7). p.836-843
Add to list
- Conference Paper
- open access
Favorable survival for endonasal endoscopic resection in locally advanced sinonasal intestinal type adenocarcinoma: a long-term comparative study

Stijn De Keukeleire (UGent) , Jens Debacker (UGent) , Tijl Vermassen (UGent) , Fréderic Duprez (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) , David Creytens (UGent) , Sylvie Rottey (UGent) and Thibaut Van Zele (UGent)

(2021) In Oral Oncology 118S(105412).
Add to list
- Journal Article
- A1
- open access
Immuno-oncological biomarkers for squamous cell cancer of the head and neck : current state of the art and future perspectives

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Elien Hilgert (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) and Sylvie Rottey (UGent)

(2021) CANCERS. 13(7).
Add to list
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Zahra Mosala Nezhad (UGent) , Tessa Kerre (UGent) , Vibeke Kruse (UGent) , Hans Van Vlierberghe (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2021) IMMUNOTHERAPY. 13(5). p.409-418
Add to list
Verrucous hyperplasia and verrucous carcinoma in head and neck : use and benefit of methotrexate

Stijn De Keukeleire (UGent) , Astrid De Meulenaere, Philippe Deron (UGent) , Wouter Huvenne (UGent) , Fréderic Duprez (UGent) , Olivier Bouckenooghe, Liesbeth Ferdinande (UGent) , David Creytens (UGent) and Sylvie Rottey (UGent)

(2021) ACTA CLINICA BELGICA. 76(6). p.487-491
Add to list
Targeting FGFR in bladder cancer : ready for clinical practice?

Stijn De Keukeleire (UGent) , Daan De Maeseneer (UGent) , Celine Jacobs (UGent) and Sylvie Rottey (UGent)

(2020) ACTA CLINICA BELGICA. 75(1). p.49-56
Add to list
To treat or not to treat? Managing comorbidities in cancer patients under immune checkpoint inhibition

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Gert De Schoenmakere, Vibeke Kruse (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2019) ACTA CLINICA BELGICA.